MILK THISTLE MARKET 規模とシェア分析 - 成長動向と予測 (2026 - 2033)
The Global Milk Thistle Market is estimated to be valued at USD 146.5 Mn in 2026 and is expected to reach USD 269.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033. This robust growth reflects increasing awareness about the health benefits of milk thistle, particularly its liver-protective properties, which are driving demand across dietary supplements and pharmaceuticals worldwide.
Milk thistle Silybum marianum is a flowering herb native to the Mediterranean region, widely recognized for its potent medicinal properties, particularly its active compound silymarin, which is known for its hepatoprotective, antioxidative, and anti-inflammatory characteristics. For centuries, milk thistle has been utilized in traditional medicine systems across Europe, Asia, and North America to treat liver disorders, gallbladder diseases, and various metabolic conditions. In the contemporary healthcare and nutraceutical landscape, milk thistle has gained significant scientific validation, driving its integration into dietary supplements, pharmaceutical formulations, herbal medicines, and functional food and beverage products.
Market Dynamics
The global milk thistle market encompasses a broad spectrum of product forms including capsules, tablets, liquid extracts, powders, and teas, catering to a diverse consumer base ranging from health-conscious individuals to patients managing chronic liver conditions. Rising consumer inclination toward plant-based and natural remedies, growing awareness about preventive healthcare, and the expanding nutraceutical industry are collectively reinforcing the commercial relevance of milk thistle on a global scale. As regulatory frameworks across major economies increasingly accommodate herbal and botanical ingredients, the milk thistle market is poised to witness sustained growth, presenting compelling opportunities for stakeholders across the value chain.
The global milk thistle market is shaped by a confluence of influential drivers, notable restraints, and emerging opportunities that collectively define its growth trajectory. On the demand side, the most prominent market driver is the escalating global burden of liver-related diseases, including non-alcoholic fatty liver disease (NAFLD), hepatitis, and cirrhosis, which has significantly amplified the clinical and consumer demand for hepatoprotective botanical solutions, with silymarin-rich milk thistle formulations being at the forefront of therapeutic and preventive interventions. Additionally, growing scientific research and clinical evidence validating the anti-inflammatory, antioxidant, and chemoprotective properties of silymarin continue to fortify the market's credibility among healthcare professionals and informed consumers alike.
Key Features of the Study
Market Segmentation
Market Segmentation
すべてのレポートを無料でカスタマイズ可能です。単独セクションの購入や国別レポートも含まれます。
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
